El SAR informa 10 veces al año los contenidos de las revistas impresas y en línea que ingresaron a la base en el mes anterior.
Este nuevo servicio que se incorpora forma parte de las actividades de transformación y modernización del CDIC.
Annals of Oncology. vol. 27(4). 2016
|
|
Molecular imaging as a tool to investigate heterogeneity of advanced HER2- positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DMI) the Zephir trial / Gebhart, G. - pág.619-624
Solicitar copia
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies / Zannoni, F.. - pág.625-634
Solicitar copia
Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes / Allenson,K. - pág.635-641
Solicitar copia
Clinical correlation of extensive-stage small-cell lung cancer genomics / Lipka, Dowlati. - pág.642-647
Solicitar copia
Positron emmision tomography response evaluation from a randomized phase lll trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas / Ramanathan, K. - pág.648-653
Solicitar copia
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase lll trial (IMPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer / Chiorean, G. - pág.654-660
Solicitar copia
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction / Klevebro, F. - pág.660-667
Solicitar copia
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK43/99 phase lll trial / Fazio, N. - pág.668-673
Solicitar copia
Quality-of-life and performance status results from the phase lll RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma / Batran,Al. - pág.673-679
Solicitar copia
|
International Journal of Radiation Oncology, Biology, Physics. vol. 94(5). 2016
|
|
Rethinking the balance of risk and benefit of androgen deprivation therapy for intermediate- risk prostate cancer / Nguyen, Paul. - pág.975-977
Solicitar copia
Exposure risk among children undergoing radiation therapy: considerations in the era of image guided radiation therapy / Hess, Clayton. - pág.978-992
Solicitar copia
Identifying predictive factors for incident reports in patients receiving radiation therapy / Elnahal,Sheeref. - pág.993-999
Solicitar copia
Variations in medicare reimbursement in radiation oncology: an analysis of the medicare provider utilization and payment data set / Vu, Charles. - pág.1000-1005
Solicitar copia
Evaluation of health economics in radiation oncology: a systematic review / Halls, Caroline. - pág.1006-104
Solicitar copia
Real-time 3d image guidance using a standard LINAC:measured motion, accuracy, and precision of the first prospective clinical trial of kilovoltage intrafraction monitoring-guided gating for prostate cancer radiation therapy / Keall,Paul. - pág.1015-1021
Solicitar copia
Prospective study delivering simultaneous integrated high-dose tumor boost with image guided apdaptive radiation therapy for radical treatment of localized muscle-invasive- bladder cancer / Hafeez, Shaista. - pág.1022-1030
Solicitar copia
Patterns of failure after radically cystectomy for PT3-4 bladder cancer: implications for adjuvant radiation therapy / Reddt, Abhinav. - pág.1031-1039
Solicitar copia
Adjuvant radiation for locally advanced bladder cancer? a question worth asking / Christodouleas, John. - pág.1040-1042
Solicitar copia
Predictive parameters of symptomatic hematochezia following 5-fraction gantry-based SABR in prostate cancer / Musunuru, Hima. - pág.1043-1051
Solicitar copia
Long-term bone marrow suppresion during postoperative chemotherapy in rectal cancer patients after preoperative chemoradiation therapy / Newman, Neil. - pág.1052-1060
Solicitar copia
Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors / Boekel, Naomi. - pág.1061-1072
Solicitar copia
Hyperthemia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis / Boekel, Naomi. - pág.1073-1080
Solicitar copia
|
Seminars in Oncology. vol. 43(2). 2016
|
|
Chronic lymphocytic leukemia: recent progress and current challenges / Woyach, Jennifer. - pág.199-200
Solicitar copia
What does it mean i have a monoclonal b-cell lymphocytosis? recent insights and new challenges / Scarfo, Lidia. - pág.209-214
Solicitar copia
MicroRNAs in chronic lymphocityc leukemia:miracle of mi rage for prognosis and targeted therapies? / Roosbroeck, Katrien. - pág.209-214
Solicitar copia
Gene mutations in chronic lymphocityc leukemia / Amin, Nisar. - pág.215-221
Solicitar copia
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade / Herman, Sara. - pág.222-232
Solicitar copia
Prognostic factors and risk stratification in chronic lymphocytic leukemia / Parikh, Sameer. - pág.233-240
Solicitar copia
Initial therapy of chronic lymphocytic leukemia / Eichorst, Barbara. - pág.241-250
Solicitar copia
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia / Maddocks, Kami. - pág.251-259
Solicitar copia
The 13 pathway: clinical inhibition in chronic lymphocytic leukemia / Brown, Jennifer. - pág.260-264
Solicitar copia
Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocityc leukemia / Blachly, James. - pág.265-273
Solicitar copia
Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia / Tam, Constantine. - pág.274-279
Solicitar copia
Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia / Robak, Tadeusz. - pág.280-290
Solicitar copia
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor t cells / Fraietta, Joseph. - pág.291-299
Solicitar copia
Secondary autoinmune cytopenias in chronic lymphocytic leukemia / Rogers, Kerry. - pág.300-310
Solicitar copia
Richter syndrome: pathogenesis and management / Rossi, Davide. - pág.311-319
Solicitar copia
|
|
